- $441.01m
- -$4.70m
- CNY10.51bn
- 48
- 68
- 49
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,100 | 5,740 | 6,866 | 9,368 | 10,506 |
Cost of Revenue | |||||
Gross Profit | 254 | 1,019 | 1,727 | 3,625 | 3,976 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,849 | 7,504 | 9,445 | 11,487 | 12,615 |
Operating Profit | -1,750 | -1,764 | -2,579 | -2,120 | -2,109 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,679 | -1,710 | -2,483 | -2,013 | -1,963 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,670 | -1,705 | -2,471 | -2,008 | -1,958 |
Net Income Before Extraordinary Items | |||||
Net Income | -1,670 | -1,705 | -2,471 | -2,008 | -1,958 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,465 | -2,081 | -2,471 | -2,008 | -1,958 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.77 | -3.12 | -2.6 | -1.98 | -1.28 |